BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7849564)

  • 1. Pretreatment with the polyamine analog 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) inhibits etoposide cytotoxicity in U-251 MG (NCI) human brain tumor cells.
    Smirnov IV; Feuerstein BG; Pellarin M; Marton LJ; Deen DF; Basu HS
    Cell Mol Biol (Noisy-le-grand); 1994 Nov; 40(7):975-80. PubMed ID: 7849564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15- triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines.
    Basu HS; Pellarin M; Feuerstein BG; Shirahata A; Samejima K; Deen DF; Marton LJ
    Cancer Res; 1993 Sep; 53(17):3948-55. PubMed ID: 8358722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of polyamine analogues to induce Z-DNA structure in synthetic polynucleotides in vitro inversely correlates with their effects on cytotoxicity of cis-diaminedichloroplatinum (II) (CDDP) in human brain tumor cell lines.
    Basu HS; Pellarin M; Feuerstein BG; Marton LJ
    Anticancer Res; 1996; 16(1):39-47. PubMed ID: 8615642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the polyamine analogs BE-3-7-3, 3-8-3, and BE-3-8-3 on human brain tumor cell growth and survival.
    Basu HS; Pellarin M; Feuerstein BG; Deen DF; Marton LJ
    Anticancer Res; 1993; 13(5A):1525-32. PubMed ID: 8239531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of N1,N14-bis(ethyl)homospermine on the growth of U-87 MG and SF-126 human brain tumor cells.
    Basu HS; Pellarin M; Feuerstein BG; Deen DF; Bergeron RJ; Marton LJ
    Cancer Res; 1990 Jun; 50(11):3137-40. PubMed ID: 2334909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
    Dolan ME; Fleig MJ; Feuerstein BG; Basu HS; Luk GD; Casero RA; Marton LJ
    Cancer Res; 1994 Sep; 54(17):4698-702. PubMed ID: 8062267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of polyamine analog-induced enhancement of cisplatin cytotoxicity in the U-251 MG human malignant glioma cell line.
    Paliwal J; Janumpalli G; Basu HS
    Cancer Chemother Pharmacol; 1998; 41(5):398-402. PubMed ID: 9523736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a polyamine analog alters DNA-matrix association in HeLa cell nuclei: a nucleoid halo assay.
    Basu HS; Wright WD; Deen DF; Roti-Roti J; Marton LJ
    Biochemistry; 1993 Apr; 32(15):4073-6. PubMed ID: 8471614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments.
    Jensen PB; Sørensen BS; Sehested M; Grue P; Demant EJ; Hansen HH
    Cancer Res; 1994 Jun; 54(11):2959-63. PubMed ID: 8187081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two active copies of the X-linked gene spermidine/spermine N1-acetyltransferase (SSAT) in a female lung cancer cell line are associated with an increase in sensitivity to an antitumor polyamine analogue.
    Mank-Seymour AR; Murray TR; Berkey KA; Xiao L; Kern S; Casero RA
    Clin Cancer Res; 1998 Aug; 4(8):2003-8. PubMed ID: 9717831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines.
    Bergeron CJ; Basu HS; Marton LJ; Deen DF; Pellarin M; Feuerstein BG
    Cancer Chemother Pharmacol; 1995; 36(5):411-7. PubMed ID: 7634383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamine analog bis(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) enhances simian virus 40 late gene expression.
    Basu HS; Dreckschmidt N; Tu L; Chanbusarakum L
    Cancer Chemother Pharmacol; 1999; 43(4):336-40. PubMed ID: 10071986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells.
    de Tinguy-Moreaud E; Pourquier P; Montaudon D; Robert J
    Anticancer Res; 1994; 14(1A):99-103. PubMed ID: 8166463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine analogue induction of programmed cell death in human lung tumor cells.
    McCloskey DE; Yang J; Woster PM; Davidson NE; Casero RA
    Clin Cancer Res; 1996 Mar; 2(3):441-6. PubMed ID: 9816189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
    Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiopotentiation of human brain tumor cells by the spermine analog N1,N14-bis(ethyl)homospermine.
    Chen CZ; Hu LJ; Bergeron RJ; Marton LJ; Deen DF
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1041-7. PubMed ID: 8083073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of a polyamine transport deficient cell line from the human non-small cell lung carcinoma line NCI H157.
    Shao D; Xiao L; Ha HC; Casero RA
    J Cell Physiol; 1996 Jan; 166(1):43-8. PubMed ID: 8557774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer.
    Pienta KJ; Smith DC
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-72-S15-77. PubMed ID: 9346227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
    Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
    Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.